or Try an Advanced Search...

    Technical Analysis for RLYB - Rallybio Corporaton

    Grade Last Price % Change Price Change
    D 1.85 -3.65% -0.07
    RLYB closed down 3.65 percent on Wednesday, May 8, 2024, on 8 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical RLYB trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Earnings Movers Other 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Support Bullish -3.65%
    Earnings Movers Other -3.65%
    Wide Bands Range Expansion -3.65%
    Crossed Above 20 DMA Bullish -1.60%
    Wide Bands Range Expansion -1.60%
    Fell Below 20 DMA Bearish 1.09%
    50 DMA Support Bullish 1.09%
    Older End-of-Day Signals for RLYB ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 13 hours ago
    Down 3% about 13 hours ago
    Fell Below 20 DMA about 13 hours ago
    20 DMA Support about 15 hours ago
    Down 2 % about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RLYB Chart by TradingView
    Basic chart:

    Profile

    Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Rare Diseases Metabolic Disorders Severe And Rare Diseases

    Is RLYB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
    Apr 17 FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
    Apr 12 RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
    Apr 12 Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Apr 11 Nasdaq Jumps 250 Points; Crude Oil Down 1%
    Apr 11 Rallybio shares gain on investment from J&J for rare fetal condition treatment
    Apr 10 Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
    Apr 10 J&J, Rallybio partner on drug development for rare fetal condition
    Apr 1 Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
    Mar 12 Rallybio GAAP EPS of -$0.50
    See more RLYB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.14
    52 Week Low 1.225
    Average Volume 1,935,267
    200-Day Moving Average 3.02
    50-Day Moving Average 1.80
    20-Day Moving Average 1.87
    10-Day Moving Average 1.83
    Average True Range 0.20
    RSI (14) 51.22
    ADX 18.14
    +DI 27.61
    -DI 18.64
    Chandelier Exit (Long, 3 ATRs) 2.86
    Chandelier Exit (Short, 3 ATRs) 2.14
    Upper Bollinger Bands 2.44
    Lower Bollinger Band 1.30
    Percent B (%b) 0.48
    BandWidth 60.65
    MACD Line 0.02
    MACD Signal Line 0.02
    MACD Histogram 0.0094
    Fundamentals Value
    Market Cap 69.92 Million
    Num Shares 37.8 Million
    EPS -1.79
    Price-to-Earnings (P/E) Ratio -1.03
    Price-to-Sales 0.00
    Price-to-Book 0.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.01
    Resistance 3 (R3) 2.02 1.98 1.98
    Resistance 2 (R2) 1.98 1.94 1.97 1.97
    Resistance 1 (R1) 1.92 1.92 1.90 1.90 1.96
    Pivot Point 1.88 1.88 1.87 1.87 1.88
    Support 1 (S1) 1.81 1.83 1.79 1.80 1.74
    Support 2 (S2) 1.77 1.81 1.76 1.73
    Support 3 (S3) 1.71 1.77 1.72
    Support 4 (S4) 1.69